Latest News
Tridek-One SAS, a biotech start-up specialised in the research and development of CD31 agonists to restore the immune balance, has closed a €16 million ($16.1m) financing round led by the Swiss VC Pureos Bioventures.
New investors Bpifrance, through its InnoBio2 fund, and Bioqube Ventures (Belgium), as well as historical investors AdBio partners and Advent Life Sciences also participated in the round.
The funds will primarily be used to identify development candidates against auto-immune diseases, to conduct IND-enabling studies and to further build the organisation. The company previously raised €3 million ($3.02 million) in a first round in 2019 involving AdBio
Global technology investor, EV Private Equity (EV), has announced the promotions of Espen Strøm and Tomas Hvamb from partner to senior partner.
Strøm will continue to lead EV’s efforts related to origination, while Hvamb will continue to head up the firm’s stewardship efforts. For over a decade at EV, both professionals have specialised in high-profile transactions, portfolio growth strategies, and exit planning.
Over the past 20 years, EV Private Equity has become established as a leading technology-enabled impact investor, committed to driving decarbonisation deep within the energy sector by shaping world-class technology companies.
Moonfare, a private equity investment platform, has surpassed $150 million in assets under management from US investors, and now offers access to private equity with minimums as low as $75k, down significantly from the previous $125k minimum.
KKR is providing individual investors with tokenised access to a portion of one of its private equity funds through a tie-up with digital assets specialist Securitise, according to a report by the Wall Street Journal.
The offering, for the second vintage of KKR’s HealthCare Strategic Growth Fund, is available to clients with at least $5 million in investable assets via the Avalanche public blockchain.
The report cites an unnamed source as saying that the tokenised position in the fund is the first ever from a major equity fund in the US. Under the terms of the offering, investors will be
Latticework Capital Management (LCM), a Dallas-based private equity firm focused exclusively on healthcare control investments in the lower middle market, has formed American Clinical Research Services Holdings (ACRS) following its acquisition of the Catalina Research Institute (CRI).
Financial terms of the transaction have not been disclosed.
CRI is an independent clinical trials centre focussed on high complexity trials across non-alcoholic steatohepatitis, non-alcoholic fatty liver disease, diabetes and other metabolic diseases as well as central nervous system. The acquisition of CRI by ACRS is the first of what is expected to be multiple investments in the broader site management organisation (SMO)
VSS Capital Partners (VSS), a private investment firm investing in the healthcare, business services, and education industries, has appointed Brad Corbin as Principal.
Corbin will work collaboratively with the VSS investment team to source new investment opportunities, perform due diligence and support portfolio company management teams to help drive value creation.
Corbin has investment experience across the healthcare, technology, and business services verticals to VSS. Prior to joining the firm, he was a Vice President with BBH Capital Partners (BBHCP), the private equity strategy of Brown Brothers Harriman & Co, where he oversaw deal execution for new platform investment
INVL-backed PET Baltija, one of the largest PolyEthylene Terephthalate (PET) recyclers in Northern Europe, has completed the acquisition of 100% of TESIL Fibres, a leading Czech fibre producer.
The acquisition of the SILON spin-off is set to increase PET Baltija’s annual turnover by more than 50% and ensure the production of higher value-added products by the company.
TESIL Fibres is the Czech Republic’s largest producer of PET fibre with 150 employees and an annual capacity of 33,000 tonnes, reaching revenues of €27 million last year. Known for its high production quality standards, the company acts as a primary fibre supplier
Global corporate finance advisory firm Clearwater International is further strengthening its presence in London with the appointment of a new Managing Partner and a move to larger premises.
Christopher Jones joins as a Managing Partner and Head of London to lead the ongoing development of the firm’s 35-strong team in the capital.
This appointment will allow fellow Managing Partner, Marcus Archer, to expand his leadership role working alongside UK CEO Mark Taylor and devote more time to his strategic role of leading private equity coverage internationally, in addition to driving the sector-focused approach to M&A across the UK.
Cascadia Capital, a US-based independent middle-market investment bank, has secured a strategic growth equity investment from an investment fund affiliated with Atlas Merchant Capital LLC.
With the additional resources from the investment and the Atlas team’s support, Cascadia will continue its geographic, product, team, multi-industry and sponsor coverage growth nationwide.
Cascadia provides businesses and investors with sub-sector nuanced guidance in a range of industries, including Business Services; Consumer & Retail; Energy Transition & Climate Tech; Food, Beverage & Agribusiness; Healthcare; Industrials; Robotics, Automation & Artificial Intelligence; and Technology. The firm will proactively hire additional experienced bankers and cohesive teams to
VSS Capital Partners (VSS), a private investment firm investing in the healthcare, business services, and education industries, has appointed Brad Corbin as principal.
Corbin will work collaboratively with the VSS investment team to source new investment opportunities, perform due diligence and support portfolio company management teams to help drive value creation.
Corbin brings investment experience across the healthcare, technology, and business services verticals to VSS. Prior to joining the firm, he was a Vice President with BBH Capital Partners (BBHCP), the private equity strategy of Brown Brothers Harriman & Co, where he oversaw deal execution for new platform investment opportunities
Special Reports
Featured
- Partner Content
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
